ArgentinogeninCAS# 4236-48-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 4236-48-0 | SDF | Download SDF |
PubChem ID | 12305202.0 | Appearance | Powder |
Formula | C24H30O6 | M.Wt | 414.5 |
Type of Compound | Steroids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-[(3S,5R,8R,10S,13R,14S,17R)-3,11,14-trihydroxy-10,13-dimethyl-12-oxo-2,3,4,5,6,7,8,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]pyran-2-one | ||
SMILES | CC12CCC(CC1CCC3C2=C(C(=O)C4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O | ||
Standard InChIKey | UJNYXLCWBDUNMH-UQPKIQGCSA-N | ||
Standard InChI | InChI=1S/C24H30O6/c1-22-9-7-15(25)11-14(22)4-5-17-19(22)20(27)21(28)23(2)16(8-10-24(17,23)29)13-3-6-18(26)30-12-13/h3,6,12,14-17,25,27,29H,4-5,7-11H2,1-2H3/t14-,15+,16-,17-,22+,23+,24+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Argentinogenin Dilution Calculator
Argentinogenin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4125 mL | 12.0627 mL | 24.1255 mL | 48.2509 mL | 60.3136 mL |
5 mM | 0.4825 mL | 2.4125 mL | 4.8251 mL | 9.6502 mL | 12.0627 mL |
10 mM | 0.2413 mL | 1.2063 mL | 2.4125 mL | 4.8251 mL | 6.0314 mL |
50 mM | 0.0483 mL | 0.2413 mL | 0.4825 mL | 0.965 mL | 1.2063 mL |
100 mM | 0.0241 mL | 0.1206 mL | 0.2413 mL | 0.4825 mL | 0.6031 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- β-Obscurin
Catalog No.:BCX1227
CAS No.:467-79-8
- Cnidimol B
Catalog No.:BCX1226
CAS No.:103629-81-8
- Erythro-guaiacylglycerol-β-O-4'-sinapyl ether
Catalog No.:BCX1225
CAS No.:905726-70-7
- threo-guaiacylglycerol-β-O-4'-sinapyl ether
Catalog No.:BCX1224
CAS No.:288864-26-6
- 5,7-Dihydroxychroman-4-one
Catalog No.:BCX1223
CAS No.:108085-46-7
- 7,3',5'-Trihydroxyflavanone
Catalog No.:BCX1222
CAS No.:847375-46-6
- 7'R,8'R-2,2'-Dimethoxy-4-(3-hydroxyl-propenyl)-4'-(1,2,3-trihydroxy-propyl) biphenyl ether
Catalog No.:BCX1221
CAS No.:515813-60-2
- 7,8,3',4'-Tetrahydroxyflavanone
Catalog No.:BCX1220
CAS No.:489-73-6
- Sinocrassoside C1
Catalog No.:BCX1219
CAS No.:909803-26-5
- Panaxcerol C
Catalog No.:BCX1218
CAS No.:63180-02-9
- Linocinnamarin
Catalog No.:BCX1217
CAS No.:554-87-0
- α-D-altro-3-Heptulofuranose
Catalog No.:BCX1216
CAS No.:25545-06-6
- 2,7-dihydroxy-4, 6-dimethoxy phenanthrene
Catalog No.:BCX1229
CAS No.:108352-70-1
- Segetalin C
Catalog No.:BCX1230
CAS No.:177602-12-9
- Dihydrobaicalin
Catalog No.:BCX1231
CAS No.:56226-98-3
- Isocoreopsin
Catalog No.:BCX1232
CAS No.:30382-18-4
- Sikokianin E
Catalog No.:BCX1233
CAS No.:2253791-96-5
- 2-(3,4-dihydroxyphenyl)-7-(β-D-glucopyranosyloxy)-8-hydroxy-4H-1-benzopyran-4-one
Catalog No.:BCX1234
CAS No.:925701-05-9
- Hedysarimcoumestan B
Catalog No.:BCX1235
CAS No.:899436-04-5
- t-OMe-Byakangelicin
Catalog No.:BCX1236
CAS No.:89560-97-4
- Albanol B
Catalog No.:BCX1237
CAS No.:87084-99-9
- Ekersenin
Catalog No.:BCX1238
CAS No.:53091-74-0
- Oxypeucedanin methanolate
Catalog No.:BCX1239
CAS No.:52939-12-5
- 1-O-gentiobiosyl-3,7-dimethoxy-8-hydroxyxanthone
Catalog No.:BCX1240
CAS No.:487040-33-5
Chemical and Pharmacological Screening of Rhinella icterica (Spix 1824) Toad Parotoid Secretion in Avian Preparations.[Pubmed:32549266]
Toxins (Basel). 2020 Jun 15;12(6):396.
The biological activity of Rhinella icterica parotoid secretion (RIPS) and some of its chromatographic fractions (RI18, RI19, RI23, and RI24) was evaluated in the current study. Mass spectrometry of these fractions indicated the presence of sarmentogenin, Argentinogenin, (5beta,12beta)-12,14-dihydroxy-11-oxobufa-3,20,22-trienolide, marinobufagin, bufogenin B, 11alpha,19-dihydroxy-telocinobufagin, bufotalin, monohydroxylbufotalin, 19-oxo-cinobufagin, 3alpha,12beta,25,26-tetrahydroxy-7-oxo-5beta-cholestane-26-O-sulfate, and cinobufagin-3-hemisuberate that were identified as alkaloid and steroid compounds, in addition to marinoic acid and N-methyl-5-hydroxy-tryptamine. In chick brain slices, all fractions caused a slight decrease in cell viability, as also seen with the highest concentration of RIPS tested. In chick biventer cervicis neuromuscular preparations, RIPS and all four fractions significantly inhibited junctional acetylcholinesterase (AChE) activity. In this preparation, only fraction RI23 completely mimicked the pharmacological profile of RIPS, which included a transient facilitation in the amplitude of muscle twitches followed by progressive and complete neuromuscular blockade. Mass spectrometric analysis showed that RI23 consisted predominantly of bufogenins, a class of steroidal compounds known for their cardiotonic activity mediated by a digoxin- or ouabain-like action and the blockade of voltage-dependent L-type calcium channels. These findings indicate that the pharmacological activities of RI23 (and RIPS) are probably mediated by: (1) inhibition of AChE activity that increases the junctional content of Ach; (2) inhibition of neuronal Na(+)/K(+)-ATPase, leading to facilitation followed by neuromuscular blockade; and (3) blockade of voltage-dependent Ca(2+) channels, leading to stabilization of the motor endplate membrane.